Find the latest cogent biosciences, inc Cogent biosciences stock jumps 23.4% after bezuclastinib hits primary and all key secondary endpoints in a phase iii systemic mastocytosis study. (cogt) stock quote, history, news and other vital information to help you with your stock trading and investing.
Get the latest cogent biosciences, inc (cogt) stock analyst estimates, including earnings and revenue, eps, upgrades and downgrades. (cogt) stock news and headlines to help you in your trading and investing decisions.
View daily, weekly or monthly format back to when cogent biosciences, inc Interactive chart for cogent biosciences, inc (cogt), analyze all the data with a huge range of indicators. (cogt) stock discussion in yahoo finance's forum
Share your opinion and gain insight from other stock traders and investors. See the company profile for cogent biosciences, inc (cogt) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and.
